학술논문
Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective
Document Type
Review Article
Source
In International Journal of Infectious Diseases March 2017 56:185-189
Subject
Language
ISSN
1201-9712